Metabolism and cell biology of vitamin K

Thrombosis and Haemostasis

Volumn 100, Issue 4, 2008, Pages 530-547

  Shearer, Martin J ^a,c   Newman, Paul ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cell biology; Gla proteins; Menaquinones; Metabolism; Oral anticoagulants; Phylloquinone; Vitamin K

Indexed keywords

2 METHYL 3 (3' CARBOXY 3' METHYLPROPYL) 1,4 NAPHTHOQUINONE; 2 METHYL 3 (5' CARBOXY 3' METHYL 2' PENTENYL) 1,4 NAPHTHOQUINONE; 2',3' DIHYDROPHYLLOQUINONE; ACENOCOUMAROL; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; APOLIPOPROTEIN E; COUMARIN; DIHYDROPHYLLOQUINONE; FARNOQUINONE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MENADIONE; MENAQUINONE; MENAQUINONE 11; MENAQUINONE 12; MENAQUINONE 7; MENATETRENONE; OSTEOCALCIN; PHYLLOQUINONE EPOXIDE; PHYTOMENADIONE; RECEPTOR; RETINOL; SPHINGOLIPID; STEROID AND XENOBIOTIC RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D; VITAMIN K GROUP; WARFARIN;

ANTICOAGULATION; BLOOD VESSEL WALL; BONE; BRAIN; CATABOLISM; CIRCULATION; CYTOLOGY; DIET; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG STRUCTURE; GENE; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; LEUKEMIA CELL; LIPOGENESIS; LIVER; LIVER CELL CARCINOMA; NEOPLASM; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OXIDATIVE STRESS; PANCREAS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; THROMBOSIS; VITAMIN K DEFICIENCY; VITAMIN K METABOLISM;

ANIMALS; ANTICOAGULANTS; BLOOD PROTEINS; HEPATOCYTES; HUMANS; OSTEOCYTES; VITAMIN K; VITAMIN K 1; VITAMIN K 2; VITAMIN K DEFICIENCY;

EID: 45849118924     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-03-0147     Document Type: Review

References (132)

1. Collins MD, Jones D. Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implications. Microbiol Rev 1981; 45: 316-354.
2. Ramotar K, et al. Production of menaquinones by intestinal anaerobes. J Infect Dis 1984; 150: 213-218.
3. Conly JM, Stein K. Quantitative and qualitative measurements of K vitamins in human intestinal contents. Am J Gastroenterol 1992; 87: 311-316.
4. Suttie JW. The importance of menaquinones in human nutrition. Annu Rev Nutr 1995; 15: 399-417.
5. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Haemostasis 2000; 30: 298-307.
6. 1) content of foods in the U.S. Food and Drug Administration's Total Diet Study. J Agric Food Chem 1995; 43: 1574-1579.
7. 1) content of foods. Br J Nutr 2000; 83: 389-399.
8. Thane CW, et al. Intake and sources of phylloquinone (vitamin K1): variation with socio-demographic and lifestyle factors in a national sample of British elderly people. Br J Nutr 2002; 87: 605-613.
9. Thane CW, et al. Comparative dietary intake and sources of phylloquinone (vitamin K1) among British adults in 1986-7 and 2000-1. Br J Nutr 2006; 96: 1105-1115.
10. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr 1998; 128: 785-788.
11. 2 (menaquinone) in the Netherlands. J Nutr Environm Med 1999; 9: 115-122.
12. Hojo K, et al. Quantitative measurement of tetrahydromenaquinone-9 in cheese fermented by propionibacteria. J Dairy Sci 2007; 90: 4078-4083.
13. Salminen S, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80: S147-S147.
14. Mathers JC, et al. Dietary modification of potential vitamin K supply from enteric bacterial menaquinones in rats. Br J Nutr 1990; 63: 639-652.
15. Shearer MJ. Vitamin K metabolism and nutriture. Blood Rev 1992; 6: 92-104.
16. 3H in man. Its intestinal absorption and transport in the thoracic duct in lymph. Int Z Vitaminforsch 1968; 38: 45-64.
17. Kohlmeier M, et al. Transport of vitamin K to bone in humans. J Nutr 1996; 126: 1192S-1196S.
18. 1) in humans. Am J Clin Nutr 1998; 67: 1226-1231.
19. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophy Acta 2002; 1570: 27-32.
20. Erkkilä AT, et al. Plasma transport of vitamin K in men using deuterium-labeled collard greens. Metabolism 2004; 53: 215-221.
21. 1 (phylloquinone) kinetics and absorption. Eur J Clin Nutr 2007; Epub: In press.
22. Olson RE, et al. Total body phylloquinone and its turnover in human subjects at two levels of vitamin K intake. Brit J Nutr 2002; 87: 543-553.
23. 1) in man. Vitamins and Hormones 1974; 32: 513-542.
24. 2 in human cortical and trabecular bone. J Bone Miner Res 1993; 8: 1005-1008.
25. 1 supplementation in women of childbearing age: effects on hemostasis. Thromb Haemost 1995; 74: 1486-1490.
26. 1 and natto-derived menaquinone-7. Blood 2007; 109: 3279-3283.
27. Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997; 38: 2173-2192.
28. Vermeer C, et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 2004; 43: 325-335.
29. Sato T, et al. Difference in the metabolism of vitamin K between liver and bone in vitamin K-deficient rats. Br J Nutr 2002; 87: 307-314.
30. Price PA, Kaneda Y. Vitamin K counteracts the effect of warfarin in liver but not in bone. Thromb Res 1987; 46: 121-131.
31. 1) by osteoblasts and osteoblast-like cells: role of heparan sulfate proteoglycans and apolipoprotein E. J Bone Miner Res 2002; 17: 426-433.
32. Weintraub MS, et al. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987; 80: 1571-1577.
33. Schilling AF, et al. Increased bone formation in mice lacking apolipoprotein E. J Bone Miner Res 2005; 20: 274-282.
34. 1 to bone. J Bone Miner Res 2005; 20: 283-293.
35. Niemeier A, et al. Uptake of postprandial lipoproteins into bone in vivo: Impact on osteoblast function. Bone 2008; 43: 230-237.
36. Shearer MJ, et al. The assessment of human vitamin K status from tissue measurements. In: Current Advances in Vitamin K Research. New York: Elsevier 1988; 437-452.
37. Thijssen HHW, Drittij-Reijnders MJ. Vitamin K status in human tissues: tissue specific accumulation of phylloquinone and menaquinone-4. Br J Nutr 1996; 75: 121-127.
38. Usui Y, et al. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 1990; 51: 846-852.
39. Thijssen HHW, Drittij-Reijnders MJ. Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br J Nutr 1994; 72: 415-425.
40. Slater EC. The possible function of quinols, chromanols and chromenols in intracellular respiration. Am J Clin Nutr 1961; 9: 50-60.
41. Martius C, Esser HO. Über die Konstitution des im Tierkörper aus Methylnaphthochinon gebildeten K-Vitamines. Biochem Z. 1958; 331: 1-9.
42. Martius C. The metabolic relationships between the different K vitamins and the synthesis of the ubiquinones. Am J Clin Nutr 1961; 9: 97-103.
43. 2(20) im Tierkörper. Biochem Z 1960; 333: 430-439.
44. Billeter M, et al. Untersuchungen über die Umwandlung von verfütterten K-Vitaminen durch Austauch der Seitenkette und die Rolle der Darmbakterien hierbei. Biochem Z 1964; 340: 290-303.
45. Will BH, et al. Comparative metabolism and requirement of vitamin K in chicks and rats. J Nutr 1992; 122: 2354-2360.
46. Ronden JE, et al. Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat. Biochim Biophys Acta 1998; 1379: 69-75.
47. Davidson RT, et al. Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J Nutr 1998; 128: 220-223.
48. Yamamoto R, et al. Menaquinone-4 accumulation in various tissues after an oral administration of phylloquinone in Wistar rats. J Nutr Sci Vitaminol (Tokyo) 1997; 43: 133-143.
49. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. Vitamin K substances. IARC Press 2000; 76: 417-486.
50. Thijssen HHW, et al. Menadione is a metabolite of oral vitamin K. Br J Nutr 2006; 95: 260-266.
51. 2) in mice: Two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 2008; 283: 11270-11279.
52. Dialameh GH, et al. Enzymatic alkylation of menaquinone-0 to menaquinones by microsomes from chick liver. Biochim Biophys Acta 1970; 223: 332-338.
53. Booth SL, et al. Age and dietary form of vitamin K affect menaquinone-4 concentrations in male Fischer 344 rats. J Nutr 2008; 138: 492-496.
54. Konishi T, et al. Whole-body autoradiographic study of vitamin K distribution in rat. Chem Pharm Bull (Tokyo) 1973; 21: 220-224.
55. Groenen-van Dooren MM, et al. Bioavailability of phylloquinone and menaquinones after oral and colorectal administration in vitamin K-deficient rats. Biochem Pharmacol 1995; 50: 797-801.
56. 1) in the urine of man. Biochim Biophys Acta 1973; 297: 300-312.
57. 1 (phylloquinone) in man. Biochem Med 1980; 24: 250-267.
58. Watanabe M, et al. Ubiquinone and related compounds. XXVI. The urinary metabolites of phylloquinone and alpha-tocopherol. Chem Pharm Bull (Tokyo) 1974; 22: 176-182.
59. Imada I, et al. Metabolism of ubiquinone-7. Biochemistry 1970; 9: 2870-2878.
60. 14C in the normal and hepatectomized rats. Thromb Diath Haemorrh 1968; 19: 383-388.
61. Harrington DJ, et al. Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res 2005; 46: 1053-1060.
62. Harrington DJ, et al. Excretion of the urinary 5C-and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 2007; 137: 1763-1768.
63. Sontag TJ, Parker RS. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 2002; 277: 25290-25296.
64. Landes N, et al. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 2003; 65: 269-273.
65. Traber MG, et al. Vitamin E revisited: do new data validate benefits for chronic disease prevention? Curr Opin Lipidol 2008; 19: 30-38.
66. Landes N, et al. Homologous metabolic and gene activating routes for vitamins E and K. Mol Aspects Med 2003; 24: 337-344.
67. 2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003; 278: 43919-43927.
68. Astedt B. Antenatal drugs affecting vitamin K status of the fetus and the newborn. Semin Thromb Hemost 1995: 21: 364-370.
69. Thierry MJ, Suttie JW. Effect of warfarin and the chloro analog of vitamin K1 on phylloquinone metabolism. Arch Biochem Biophys 1971; 147: 430-435.
70. Konishi T, et al. Intracellular and intramitochondrial distribution of vitamin K: biochemical and electron microscopic radioautographic study. Chem Pharm Bull (Tokyo) 1973; 21: 2479-2487.
71. Ross PJ, et al. A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonists. Br J Haematol 1991; 77: 195-200.
72. Gundberg CM, et al. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 1998; 83: 3258-3266.
73. Will BH, Suttie JW. Comparative metabolism of phylloquinone and menaquinone-9 in rat liver. J Nutr 1992; 122: 953-958.
74. Haffa A, et al. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. J Bone Miner Res 2000; 15: 872-878.
75. Duello TJ, Matschiner JT. Characterization of vitamin K from human liver. J Nutr 1972; 102: 331-336.
76. Booth SL, et al. Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr 2001; 74: 783-790.
77. Ferland G, et al. Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest 1993; 91: 1761-1768.
78. Matschiner JT, et al. Isolation and characterization of a new metabolite of phylloquinone in the rat. Biochim Biophys Acta 1970; 201: 309-315.
79. Price PA, et al. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400-1407.
80. Wallin R, et al. Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells: a cell system which resembles the system in bone cells. Thromb Haemost 1999; 82: 1764-1767.
81. Schurgers LJ, et al. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007; 109: 2823-2831.
82. 3H in the rat. Biochemistry 1969; 8: 1141-1146.
83. Schurgers LJ, et al. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 2004; 104: 2682-2689.
84. Sconce E, et al. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005; 93: 872-875.
85. Sconce E, et al. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007; 109: 2419-2423.
86. Rombouts EK, et al. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost 2007; 5: 2043-2048.
87. Stafford DW, et al. Vitamin K supplementation during oral anticoagulation: cautions. Blood 2007; 109: 3607.
88. Sconce E, et al. Vitamin K supplementation during oral anticoagulation: no real cause for concern. Blood 2007; 109: 3607-3608.
89. Schurgers LJ, et al. Oral anticoagulant treatment: friend or foe in cardiovascular disease. Blood 2004; 104: 3231-3232.
90. Matschiner JT, Doisy EA. Bioassay of vitamin K in chicks. J Nutr 1966; 90: 97-100.
91. Matschiner JT, Taggart WV. Bioassay of vitamin K by intracardial injection in deficient adult male rats. J Nutr 1968; 94: 57-59.
92. 3 as cofactors for the hepatic vitamin K-dependent carboxylase. Biochim Biophys Acta 1990; 1034: 170-175.
93. Hodges SJ, et al. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 1991; 12: 387-389.
94. Orimo H, et al. Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis-a double blind multicenter comparative study with 1α hydroxy vitamin D3. J Bone Miner Res 1992 (Suppl 1); 7: S122.
95. Akiyama Y, et al. Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol 1993; 62: 145-153.
96. Hara K, et al. Effects of menatetrenone on prednisolone-induced bone loss in rats. Bone 1993; 14: 813-818.
97. Koshihara Y, et al. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. Biochem Pharmacol 1993; 46: 1355-1362.
98. Akiyama Y, et al. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur J Pharmacol 1994; 263: 181-185.
99. 2 (menatetrenone) on bone resorption may be related to its side chain. Bone 1995; 16: 179-184.
100. Nanke Y, et al. Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats. Calcif Tissue Int 2005; 77: 376-385.
101. Kearns AE, et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodelling in health and disease. Endocr Rev 2008; 29: 155-192.
102. Hiruma Y, et al. Vitamin K2 and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner. Biochem Biophys Res Commun 2004; 314: 24-30.
103. KoshiharaY, et al. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol 2003; 176: 339-348.
104. Kameda T, et al. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 1996; 220: 515-519.
105. Sakai I, et al. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukaemia cell lines. Biochem Biophys Res Commun 1994; 205: 1305-1310.
106. Yaguchi M, et al. Vitamin K2 and its derivatives induce apoptosis in leukaemia cells and enhance the effect of all-trans retinoic acid. Leukemia 1997; 11: 779-787.
107. Masuda Y, et al. Geranylgeraniol potently induces caspase-3-like activity during apoptosis in human leukaemia U937 cells. Biochem Biophys Res Commun 1997; 234: 641-645.
108. Tokita H, et al. Vitamin K2-induced antitumor effects via cell-cycle arrest and apoptosis in gastric cancer cell lines. Int J Mol Med 2006; 17: 235-243.
109. Ogawa M, et al. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int J Oncol 2007; 31: 323-331.
110. 2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. J Am Med Assoc 2004; 292: 358-361.
111. Mizuta T, et al. The effect of Menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study. Cancer 2006; 106: 867-872.
112. Kuriyama S, et al. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules. Int J Oncol 2005; 27: 505-511.
113. Ozaki I, et al. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res 2007, 13: 2236-2245.
114. 2 binding protein in human osteoblasts: homologue to glyceraldehyde-3-phosphate dehydrogenase. Biochem Pharmacol 1999; 58: 1631-1638.
115. 2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 2006; 281: 16927-16934.
116. Igarashi M, et al. Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene. Mol Cell Biol 2007; 27: 7947-7954.
117. Ichikawa T, et al. Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. J Mol Endocrinol 2007; 39: 239-247.
118. Ronden JE, et al. Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains. Atherosclerosis 1997; 132: 61-67.
119. Reddi K, et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 1995; 3: 287-290.
120. Ohsaki Y, et al. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006; 70: 926-932.
121. Shea MK, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008; 167: 313-320.
122. Li J, et al. Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci 2003; 23: 5816-5826.
123. Mukai K, et al. Kinetic study of free-radical-scavenging action of biological hydroquinones (reduced forms of ubiquinone, vitamin K and tocopherol quinone) in solution. Biochim Biophys Acta 1993; 1157: 313-317.
124. Vervoort LMT, et al. The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation. Biochem Pharmacol 1997; 54: 871-876.
125. Lev M, Milford AF. Effect of vitamin K depletion and restoration on sphingolipid metabolism in Bacteroides melaninogenicus. J Lipid Res 1972; 13: 364-370.
126. Sundaram KS, Lev M. Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain. J Lipid Res 1988; 29: 1475-1479.
127. Sundaram KS, Lev M. Regulation of sulfotransferase activity by vitamin K in mouse brain. Arch Biochem Biophys 1990; 277: 109-113.
128. Sundaram KS, et al. Vitamin K status influences brain sulfatide metabolism in young mice and rats. J Nutr 1996; 126: 2746-2751.
129. Carrié I, et al. Menaquinone-4 concentration is correlated with sphingolipid concentrations in rat brain. J Nutr 2004; 134: 167-172.
130. Cocchetto DM, et al. Behavioral perturbations in the vitamin K-deficient rat. Physiol Behav 1985; 34: 727-734.
131. Thomas DDH, et al. Exocrine pancreatic secretion of phospholipid, menaquinone-4, and caveolin-1 in vivo. Biochem Biophys Res Commun 2004; 319: 974-979.
132. Stenberg LM, et al. Synthesis of gamma-carboxylated polypeptides by alpha-cells of the pancreatic islets. Biochem Biophys Res Commun 2001; 283: 454-459.